Study to Assess the Safety, Tolerance and Efficacy of Tezampanel in Patients With Acute Migraine
Clinical trial NCT00567086 · COMPLETED
Trial details
- NCT number
- NCT00567086
- Sponsor
- TorreyPines Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-10-01
- Enrollment
- 306
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.